Longtime FDA oncology leader named agency’s top drug regulator
The US Food and Drug Administration said Tuesday that Dr. Richard Pazdur has been named head of the Center for Drug Evaluation and Research, its largest division, which oversees the safety and ...
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’
A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns ...
UniQure: Controversy Abounds As Stock Price Halves On FDA News
UniQure shares soared on positive AMT-130 Huntington's disease data, but plunged after the FDA reversed its stance on ...
New Bedford council, School Committee candidates in 2025 election share their platforms
Before you cast your ballot, here's what the candidates running in New Bedford's upcoming election had to say: ...
The Owensboro Times
What’s happening at the animal shelter? A look at the claims, responses, data
Tensions surrounding the Daviess County animal shelter have intensified in recent months, with conflicting claims about ...
Former Stanford professor accused of 'reprehensible' conduct quits top FDA job
Hilliard, the HHS spokesperson, told SFGATE on Tuesday that, “Secretary [Robert F.] Kennedy [Jr.] expects the highest ethical ...
F.D.A. Names Agency Veteran to Run Drug Division
Dr. Richard Pazdur, who has been the F.D.A.’s top cancer drug regulator, represents a stabilizing choice for an agency ...
RFK Jr. Discussed Curbing FDA Head’s Role After Complaints About Management Style
Health Secretary Robert F. Kennedy Jr. considered installing a new leader to manage the agency on a day-to-day basis.
US FDA's drug division chief resigns amid ethics concerns and lawsuit
The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on ...
BioPharma Dive
Richard Pazdur, longtime FDA oncology leader, to head agency’s main drug office
The appointment of Pazdur as CDER head comes shortly after the surprise ousting of George Tidmarsh and should quiet many of ...
FDA to lift black box warnings from menopause hormone therapies
The U.S. Food and Drug Administration said on Monday (November 10) it would remove the strictest "black box" warnings from ...
HealthDay on MSN
Top FDA Drug Chief Resigns While Under Investigation
Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just days after he was placed on administrative leave while federal officials ...